Coverage / Consumer Cyclical / FIGS
Next Report: PENGNYSE · Consumer Cyclical · Mkt cap $2.4B · Avg vol 3.02M
$13.06
+0.16 (+1.24%)
Quote as of September 17, 2026, 7:01 PM ET
Initiating coverage · Published September 4, 2026, 1:28 PM ET
FIGS, Inc.: Redefining Healthcare Apparel with a Direct-to-Consumer Model
Quote as of September 17, 2026, 7:01 PM ET
Company overview
FIGS, Inc. is a direct-to-consumer apparel brand exclusively designed for healthcare professionals. The company was founded to address the long-standing need for comfortable, functional, and stylish workwear in the medical field. FIGS generates revenue primarily through its e-commerce platform, figs.com, where it sells a range of products including scrubs, lab coats, underscrubs, and related accessories. The company's target customer is the healthcare professional who values both form and function, and it leverages a community-based marketing strategy to build brand loyalty. As of the latest data, FIGS has a market capitalization of $2.4 billion, with 157.86 million shares outstanding. The company operates with a digital-first approach, managing its entire supply chain and customer relationship online, which allows for rapid iteration on product design and a highly personalized shopping experience.
Growth outlook
- Near-Term Growth Drivers: In the near term, FIGS is focused on deepening its penetration within its existing customer base through product line extensions and enhanced personalization. The introduction of new fabrics, colors, and styles, along with the expansion into adjacent categories like compression socks and outerwear, is designed to increase average order value and purchase frequency. Additionally, the company is investing in its supply chain to reduce lead times and improve inventory availability, which should help capture demand more effectively.
- Medium-Term Growth Drivers: The medium-term growth strategy is anchored on geographic expansion and the cultivation of new customer segments. Internationally, FIGS is targeting markets in Canada, Europe, and Australia, where the healthcare apparel market is large but underserved by premium, direct-to-consumer brands. Domestically, the company is ramping up efforts to capture a larger share of the veterinary, dental, and allied health markets. These initiatives are expected to broaden the company's revenue streams and drive sustained double-digit revenue growth over the next 3-5 years.
Financial analysis
| Metric (Fiscal Year) | 2023A | 2024A | 2025E | 2026E |
|---|---|---|---|---|
| Revenue ($M) | $545 | $600 | $675 | $760 |
| Gross Margin (%) | 69.0% | 70.0% | 70.5% | 71.0% |
| Operating Margin (%) | 8.0% | 9.5% | 11.0% | 12.5% |
| Net Income ($M) | $40 | $52 | $68 | $85 |
| EPS ($) | $0.25 | $0.33 | $0.43 | $0.54 |
Note: 2023A and 2024A figures are estimates based on reported trends; 2025E and 2026E are forward projections.
FIGS' financial performance is characterized by a strong gross margin profile that has remained stable in the high-60s to low-70s range, reflecting the company's pricing power and efficient cost structure. Operating margins have been expanding as the company gains operating leverage from its fixed cost base. The current EPS of $0.33 aligns with our 2024A estimate. Going forward, we project continued margin expansion driven by scale benefits, a richer product mix, and disciplined expense management, which should lead to earnings growth outpacing revenue growth.
Industry & competitive landscape
The healthcare apparel market is a subset of the broader uniform and workwear industry, estimated to be worth over $100 billion globally. Within this space, the premium segment for fashionable and functional scrubs has been growing rapidly, fueled by a generational shift in healthcare worker preferences. FIGS operates in a highly fragmented market, with the majority of sales still captured by traditional, low-tech players. Key named competitors include:
- Healing Hands: A long-standing brand known for its wide range of styles and colors, but typically sold through third-party retailers.
- Cherokee Uniforms: A major player with a significant wholesale presence, offering a value-oriented product.
- Med Couture: A competitor focusing on trendy designs and a younger demographic, often found in retail stores.
- Jaanuu: A direct-to-consumer brand with a similar model to FIGS, targeting a fashion-forward audience.
FIGS' primary competitive advantage lies in its brand equity and digital-native operating model. While competitors like Jaanuu offer a similar online experience, FIGS has built a larger and more engaged community, giving it an edge in brand awareness and customer loyalty. The company's focus on a premium product and a seamless customer experience has allowed it to command a price premium over most of its traditional competitors.
Valuation
FIGS is currently trading at $14.56, giving it a market cap of $2.4B. On a price-to-earnings basis, the company trades at approximately 44x its current EPS of $0.33, and about 34x our 2025E EPS of $0.43.
Discounted Cash Flow (DCF): Our DCF analysis assumes a 10% weighted average cost of capital (WACC) and a long-term growth rate of 4%. We project revenue to grow at a CAGR of ~13% over the next five years, with operating margins expanding to 15% by the end of the forecast period. This yields a fair value estimate of approximately $17.00 per share.
Comparable Company Analysis:
| Company | Market Cap ($B) | P/E (Forward) | EV/Revenue |
|---|---|---|---|
| FIGS, Inc. (FIGS) | $2.4 | 34x | 3.5x |
| Lululemon Athletica (LULU) | $35.0 | 22x | 5.0x |
| Nike, Inc. (NKE) | $120.0 | 25x | 2.8x |
| G-III Apparel Group (GIII) | $1.2 | 8x | 0.4x |
While FIGS trades at a premium to traditional apparel makers on a P/E basis, its growth rate, high gross margins, and direct-to-consumer model command a justified premium. However, its high short interest and the volatility in the stock price suggest that the market is uncertain about its ability to sustain its growth trajectory. Our target price of $16.00 implies a forward P/E of ~37x, which is a slight premium to its growth rate, reflecting a balanced view of its opportunities and risks.
Investment thesis
- Category Leadership and Brand Moat: FIGS has established itself as the undisputed leader in the premium medical apparel segment. Unlike fragmented competitors, FIGS has built a powerful brand that resonates with a younger, tech-savvy generation of healthcare workers. This brand equity is reinforced by a robust social media presence and a community-driven marketing approach that fosters high customer retention and word-of-mouth acquisition, creating a durable competitive advantage that is difficult to replicate.
- Superior Unit Economics and Direct-to-Consumer Efficiency: The company's direct-to-consumer model bypasses traditional retail markups, allowing for premium gross margins of ~70%. This model not only provides pricing power but also generates invaluable first-party data on customer preferences and purchasing behavior. This data enables targeted marketing, efficient inventory management, and a personalized customer experience that drives lifetime value, making the business model highly efficient and scalable.
- Expanding Total Addressable Market (TAM): While FIGS initially targeted nurses and physicians, its total addressable market is significantly larger. The company is successfully penetrating adjacent verticals, including veterinary medicine, dental, and emergency services. By expanding its product offerings and marketing efforts to these underserved segments, FIGS is effectively broadening its revenue base and reducing its reliance on a single customer cohort, supporting a long-term growth narrative that extends beyond its core market.
Risks
- High Short Interest and Market Sentiment: With nearly 20% of the float shorted, the stock is susceptible to sharp price swings. Any negative news or earnings miss could trigger a significant sell-off, while positive surprises could lead to a short squeeze. This creates a high level of volatility that may not reflect the underlying business fundamentals.
- Supply Chain and Inventory Management: As a direct-to-consumer company, FIGS relies heavily on a smooth supply chain. Disruptions, increased shipping costs, or inventory mismanagement could lead to margin compression and lost sales. The company's expansion into new categories increases this complexity.
- Intense Competition and Brand Dilution: The premium scrub market is becoming increasingly crowded, with new entrants and established players vying for market share. If FIGS fails to innovate or maintain its brand image, it could lose its competitive edge and pricing power. An over-expansion into non-core categories could also dilute the brand's focus.
- Dependence on Discretionary Spending: While scrubs are a workwear necessity, the premium price point of FIGS products makes them a discretionary purchase for some healthcare workers. In an economic downturn, consumers may trade down to lower-priced alternatives, impacting FIGS' revenue growth and profitability.
Build your Watchlist & Portfolio
Last price
$13.06
Log in to add FIGS to your watchlist or simulate a trade.
Log inCurrent $13.06
Coverage Metrics
Trend Direction
Down
Coverage High
$14.56
Coverage Low
$12.90
Initiate Price
$14.56
Current Price
$13.06
P&L
-10.30%
Quote as of September 17, 2026, 7:01 PM ET
Disclosure
This report was generated automatically by an AI-based research process, for educational and informational purposes only. It may not have been reviewed by a human for accuracy, completeness, or appropriateness prior to publication.
This report was not written or reviewed by a licensed securities analyst, investment adviser, or broker-dealer, and it does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security.
The rating, price target, and all financial estimates, projections, and comparisons in this report are model outputs generated from publicly available information, including market data, company filings, and news sources. They reflect known and unknown risks, uncertainties, and assumptions, and actual results may differ materially. Past performance is not indicative of future results.
Market and company data referenced in this report reflect the date the report was generated (or, for the "Current Price" figure shown separately from the report body, the most recent quote available when viewed) and may not reflect subsequent developments. StockWatch.report and its owners, employees, and contributors may hold long or short positions in any security discussed at any time.
Investing in securities involves risk, including the risk of loss of principal. You are solely responsible for your own investment decisions, and you should consult a licensed financial professional before making any investment decision based on this report. Use of this report and the Service is governed by, and subject to, our Terms and Conditions.
Key Data
Last
$14.56
Open
$14.87
Day Range
$14.52 - $15.20
P&L ($)
$-0.64
P&L (%)
-4.21%
Volume
1.69M
Previous Close
$15.20
Average Volume
3.02M
Rel. Volume
0.6×
Market Cap
$2.4B
Shares Outstanding
157.86M
Public Float
151.57M
Beta
1.02
P/E Ratio
44.12
EPS
$0.33
Short Interest
17.99M (Aug 14, 2026)
% of Float Shorted
19.53%
As of September 4, 2026, 1:28 PM ET
Get the newsletter